Trial intelligence / Profile preview

Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness

NCT02136420Phase 4Completed

Sponsor
Massachusetts Eye and Ear
Start
Jun 2014
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of promethazine in motion sickness, sponsored by Massachusetts Eye and Ear. Started Jun 2014; status: completed.

02

Drugs

promethazine
03

Conditions

motion sickness

Beyond the preview

Go deeper on NCT02136420.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02136420.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call